New Issue: ABN Amro prices $150,000 10% reverse convertibles linked to Pfizer

By Susanna Moon

Chicago, June 27 - ABN Amro Bank NV priced $150,000 of 10% Knock-In Reverse Exchangeable notes due June 30, 2009 linked to Pfizer Inc. shares, according to a 424B2 filing with the Securities and Exchange Commission.

Payout at maturity will be par in cash unless Pfizer shares fall below the protection price - 85% of the initial price - during the life of the notes and finishes below the initial price, in which case the payout will be a number of Pfizer shares equal to $1,000 divided by the initial share price.

ABN Amro Inc. is the agent.

Issuer:	ABN Amro Bank NV
Issue:	Knock-In Reverse Exchangeable notes
Underlying stock:	Pfizer Inc. (Symbol: PFE)
Amount:	$150,000
Maturity:	June 30, 2009
Coupon:	10%, payable monthly
Price:	Par
Payout at maturity:	Par in cash unless Pfizer stock falls below the protection price and finishes below the initial price, in which case 55.928 Pfizer shares
Initial share price:	$17.88
Protection price:	$15.20, or 85% of initial price
Pricing date:	June 25
Settlement date:	June 30
Agent:	ABN Amro Inc.
Fees:	2.5%

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.